Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has provided an update.
EZZ Life Science Holdings Ltd. reported a slight increase in revenue by 0.65% to $66.87 million for the year ending June 2025, while profits decreased by 3.36% to $6.73 million. Despite the decline in profit, the company saw an increase in net assets and share capital, indicating a strengthening financial position. The dividends remained consistent with the previous year, reflecting stable shareholder returns. These financial results suggest a resilient performance amidst challenging market conditions, potentially impacting stakeholder confidence positively.
The most recent analyst rating on (AU:EZZ) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Ltd. operates in the life sciences industry, focusing on the development and distribution of health and wellness products. The company is engaged in providing a range of products aimed at improving health and quality of life, with a market focus on innovative solutions for consumers.
Average Trading Volume: 105,106
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$116M
Find detailed analytics on EZZ stock on TipRanks’ Stock Analysis page.